Review




Structured Review

Absolute Biotech Inc goat anti–munc13-4
CTLs from patients UPN396 and UPN324 show severely reduced ability to kill target cells. A, Percentage killing of P815 target cells by means of redirected lysis with anti-CD3 mediated by CTLs from a healthy donor ( HD ; triangles ), patient UPN324 (squares) , and patient UPN396 (circles) after 4 hours. Each data point was run in triplicates. The image is representative of 3 independent experiments. B, Immunoblots of Rab27a and <t>Munc13-4</t> in CTLs from a healthy donor (HD) and patients UPN324 and UPN396. Proteins from lysates were separated by means of SDS-PAGE, transferred onto nitrocellulose, and probed with protein-specific antibodies against Rab27a, Munc13-4, and actin. Images are representative of 3 independent experiments.
Goat Anti–Munc13 4, supplied by Absolute Biotech Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/goat+anti%E2%80%93munc13-4/goat+anti+munc13+4/pmc04418747-62-56-57
Average 90 stars, based on 1 article reviews
goat anti–munc13-4 - by Bioz Stars, 2026-09
90/100 stars

Images

1) Product Images from "Patients with Griscelli syndrome and normal pigmentation identify RAB27A mutations that selectively disrupt MUNC13-4 binding"

Article Title: Patients with Griscelli syndrome and normal pigmentation identify RAB27A mutations that selectively disrupt MUNC13-4 binding

Journal: The Journal of Allergy and Clinical Immunology

doi: 10.1016/j.jaci.2014.08.039

CTLs from patients UPN396 and UPN324 show severely reduced ability to kill target cells. A, Percentage killing of P815 target cells by means of redirected lysis with anti-CD3 mediated by CTLs from a healthy donor ( HD ; triangles ), patient UPN324 (squares) , and patient UPN396 (circles) after 4 hours. Each data point was run in triplicates. The image is representative of 3 independent experiments. B, Immunoblots of Rab27a and Munc13-4 in CTLs from a healthy donor (HD) and patients UPN324 and UPN396. Proteins from lysates were separated by means of SDS-PAGE, transferred onto nitrocellulose, and probed with protein-specific antibodies against Rab27a, Munc13-4, and actin. Images are representative of 3 independent experiments.
Figure Legend Snippet: CTLs from patients UPN396 and UPN324 show severely reduced ability to kill target cells. A, Percentage killing of P815 target cells by means of redirected lysis with anti-CD3 mediated by CTLs from a healthy donor ( HD ; triangles ), patient UPN324 (squares) , and patient UPN396 (circles) after 4 hours. Each data point was run in triplicates. The image is representative of 3 independent experiments. B, Immunoblots of Rab27a and Munc13-4 in CTLs from a healthy donor (HD) and patients UPN324 and UPN396. Proteins from lysates were separated by means of SDS-PAGE, transferred onto nitrocellulose, and probed with protein-specific antibodies against Rab27a, Munc13-4, and actin. Images are representative of 3 independent experiments.

Techniques Used: Lysis, Western Blot, SDS Page

Effect of mutations in Rab27a on binding to Mlph and Munc13-4. Immunoblots showing coimmunoprecipitations are shown. A, Munc13-4 with Rab27a ( lanes 1 and 2 ), Rab27a-S163R ( lanes 3 and 4 ), and Rab27a-R141lfs ( lanes 5 and 6 ). Images are representative of 3 independent experiments. B, Rab27a ( lanes 1 and 2 ), Rab27a-S163R ( lanes 3 and 4 ), and Rab27a-R141lfs ( lanes 5 and 6 ) with Mlph. Membranes were probed with specific antibodies against Rab27a (top) or Mlph (bottom) . C and D, As above but with Rab27A A76V and Y159C. Proteins were immunoprecipitated with anti-Munc13-4 or Mlph and probed for Rab27a, Munc13-4, and Mlph.
Figure Legend Snippet: Effect of mutations in Rab27a on binding to Mlph and Munc13-4. Immunoblots showing coimmunoprecipitations are shown. A, Munc13-4 with Rab27a ( lanes 1 and 2 ), Rab27a-S163R ( lanes 3 and 4 ), and Rab27a-R141lfs ( lanes 5 and 6 ). Images are representative of 3 independent experiments. B, Rab27a ( lanes 1 and 2 ), Rab27a-S163R ( lanes 3 and 4 ), and Rab27a-R141lfs ( lanes 5 and 6 ) with Mlph. Membranes were probed with specific antibodies against Rab27a (top) or Mlph (bottom) . C and D, As above but with Rab27A A76V and Y159C. Proteins were immunoprecipitated with anti-Munc13-4 or Mlph and probed for Rab27a, Munc13-4, and Mlph.

Techniques Used: Binding Assay, Western Blot, Immunoprecipitation

Related Articles

Produced:

Article Title: Patients with Griscelli syndrome and normal pigmentation identify RAB27A mutations that selectively disrupt MUNC13-4 binding
Article Snippet: Lysates were precleared with 100 μL of Protein G Bead slurry (GE Healthcare, Fairfield, Conn) with rotating at 4°C for 30 minutes and then split into 3 samples: no antibody, rabbit anti-Rab27a (produced in rabbits immunized with human Rab27a-GST and screened against lysates from healthy donor and Rab27A-deficient human and mouse cell lines), and either goat anti–Munc13-4 (Everest Biotechnology, Upper Heyford, United Kingdom) or rabbit anti-Mlph (Abcam, Cambridge, United Kingdom).

Lysis:

Article Title: Patients with Griscelli syndrome and normal pigmentation identify RAB27A mutations that selectively disrupt MUNC13-4 binding
Article Snippet: Lysates were precleared with 100 μL of Protein G Bead slurry (GE Healthcare, Fairfield, Conn) with rotating at 4°C for 30 minutes and then split into 3 samples: no antibody, rabbit anti-Rab27a (produced in rabbits immunized with human Rab27a-GST and screened against lysates from healthy donor and Rab27A-deficient human and mouse cell lines), and either goat anti–Munc13-4 (Everest Biotechnology, Upper Heyford, United Kingdom) or rabbit anti-Mlph (Abcam, Cambridge, United Kingdom).

Western Blot:

Article Title: Patients with Griscelli syndrome and normal pigmentation identify RAB27A mutations that selectively disrupt MUNC13-4 binding
Article Snippet: Lysates were precleared with 100 μL of Protein G Bead slurry (GE Healthcare, Fairfield, Conn) with rotating at 4°C for 30 minutes and then split into 3 samples: no antibody, rabbit anti-Rab27a (produced in rabbits immunized with human Rab27a-GST and screened against lysates from healthy donor and Rab27A-deficient human and mouse cell lines), and either goat anti–Munc13-4 (Everest Biotechnology, Upper Heyford, United Kingdom) or rabbit anti-Mlph (Abcam, Cambridge, United Kingdom).

SDS Page:

Article Title: Patients with Griscelli syndrome and normal pigmentation identify RAB27A mutations that selectively disrupt MUNC13-4 binding
Article Snippet: Lysates were precleared with 100 μL of Protein G Bead slurry (GE Healthcare, Fairfield, Conn) with rotating at 4°C for 30 minutes and then split into 3 samples: no antibody, rabbit anti-Rab27a (produced in rabbits immunized with human Rab27a-GST and screened against lysates from healthy donor and Rab27A-deficient human and mouse cell lines), and either goat anti–Munc13-4 (Everest Biotechnology, Upper Heyford, United Kingdom) or rabbit anti-Mlph (Abcam, Cambridge, United Kingdom).

Binding Assay:

Article Title: Patients with Griscelli syndrome and normal pigmentation identify RAB27A mutations that selectively disrupt MUNC13-4 binding
Article Snippet: Lysates were precleared with 100 μL of Protein G Bead slurry (GE Healthcare, Fairfield, Conn) with rotating at 4°C for 30 minutes and then split into 3 samples: no antibody, rabbit anti-Rab27a (produced in rabbits immunized with human Rab27a-GST and screened against lysates from healthy donor and Rab27A-deficient human and mouse cell lines), and either goat anti–Munc13-4 (Everest Biotechnology, Upper Heyford, United Kingdom) or rabbit anti-Mlph (Abcam, Cambridge, United Kingdom).

Immunoprecipitation:

Article Title: Patients with Griscelli syndrome and normal pigmentation identify RAB27A mutations that selectively disrupt MUNC13-4 binding
Article Snippet: Lysates were precleared with 100 μL of Protein G Bead slurry (GE Healthcare, Fairfield, Conn) with rotating at 4°C for 30 minutes and then split into 3 samples: no antibody, rabbit anti-Rab27a (produced in rabbits immunized with human Rab27a-GST and screened against lysates from healthy donor and Rab27A-deficient human and mouse cell lines), and either goat anti–Munc13-4 (Everest Biotechnology, Upper Heyford, United Kingdom) or rabbit anti-Mlph (Abcam, Cambridge, United Kingdom).



Similar Products

90
Novus Biologicals goat anti munc13 4
Goat Anti Munc13 4, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/goat+anti%E2%80%93munc13-4/UNC13D%2FMunc+13-4+Antibody/pmc04798968-321-29-32
Average 90 stars, based on 1 article reviews
goat anti munc13 4 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Absolute Biotech Inc goat anti–munc13-4
CTLs from patients UPN396 and UPN324 show severely reduced ability to kill target cells. A, Percentage killing of P815 target cells by means of redirected lysis with anti-CD3 mediated by CTLs from a healthy donor ( HD ; triangles ), patient UPN324 (squares) , and patient UPN396 (circles) after 4 hours. Each data point was run in triplicates. The image is representative of 3 independent experiments. B, Immunoblots of Rab27a and <t>Munc13-4</t> in CTLs from a healthy donor (HD) and patients UPN324 and UPN396. Proteins from lysates were separated by means of SDS-PAGE, transferred onto nitrocellulose, and probed with protein-specific antibodies against Rab27a, Munc13-4, and actin. Images are representative of 3 independent experiments.
Goat Anti–Munc13 4, supplied by Absolute Biotech Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/goat+anti%E2%80%93munc13-4/goat+anti+munc13+4/pmc04418747-62-56-57
Average 90 stars, based on 1 article reviews
goat anti–munc13-4 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


CTLs from patients UPN396 and UPN324 show severely reduced ability to kill target cells. A, Percentage killing of P815 target cells by means of redirected lysis with anti-CD3 mediated by CTLs from a healthy donor ( HD ; triangles ), patient UPN324 (squares) , and patient UPN396 (circles) after 4 hours. Each data point was run in triplicates. The image is representative of 3 independent experiments. B, Immunoblots of Rab27a and Munc13-4 in CTLs from a healthy donor (HD) and patients UPN324 and UPN396. Proteins from lysates were separated by means of SDS-PAGE, transferred onto nitrocellulose, and probed with protein-specific antibodies against Rab27a, Munc13-4, and actin. Images are representative of 3 independent experiments.

Journal: The Journal of Allergy and Clinical Immunology

Article Title: Patients with Griscelli syndrome and normal pigmentation identify RAB27A mutations that selectively disrupt MUNC13-4 binding

doi: 10.1016/j.jaci.2014.08.039

Figure Lengend Snippet: CTLs from patients UPN396 and UPN324 show severely reduced ability to kill target cells. A, Percentage killing of P815 target cells by means of redirected lysis with anti-CD3 mediated by CTLs from a healthy donor ( HD ; triangles ), patient UPN324 (squares) , and patient UPN396 (circles) after 4 hours. Each data point was run in triplicates. The image is representative of 3 independent experiments. B, Immunoblots of Rab27a and Munc13-4 in CTLs from a healthy donor (HD) and patients UPN324 and UPN396. Proteins from lysates were separated by means of SDS-PAGE, transferred onto nitrocellulose, and probed with protein-specific antibodies against Rab27a, Munc13-4, and actin. Images are representative of 3 independent experiments.

Article Snippet: Lysates were precleared with 100 μL of Protein G Bead slurry (GE Healthcare, Fairfield, Conn) with rotating at 4°C for 30 minutes and then split into 3 samples: no antibody, rabbit anti-Rab27a (produced in rabbits immunized with human Rab27a-GST and screened against lysates from healthy donor and Rab27A-deficient human and mouse cell lines), and either goat anti–Munc13-4 (Everest Biotechnology, Upper Heyford, United Kingdom) or rabbit anti-Mlph (Abcam, Cambridge, United Kingdom).

Techniques: Lysis, Western Blot, SDS Page

Effect of mutations in Rab27a on binding to Mlph and Munc13-4. Immunoblots showing coimmunoprecipitations are shown. A, Munc13-4 with Rab27a ( lanes 1 and 2 ), Rab27a-S163R ( lanes 3 and 4 ), and Rab27a-R141lfs ( lanes 5 and 6 ). Images are representative of 3 independent experiments. B, Rab27a ( lanes 1 and 2 ), Rab27a-S163R ( lanes 3 and 4 ), and Rab27a-R141lfs ( lanes 5 and 6 ) with Mlph. Membranes were probed with specific antibodies against Rab27a (top) or Mlph (bottom) . C and D, As above but with Rab27A A76V and Y159C. Proteins were immunoprecipitated with anti-Munc13-4 or Mlph and probed for Rab27a, Munc13-4, and Mlph.

Journal: The Journal of Allergy and Clinical Immunology

Article Title: Patients with Griscelli syndrome and normal pigmentation identify RAB27A mutations that selectively disrupt MUNC13-4 binding

doi: 10.1016/j.jaci.2014.08.039

Figure Lengend Snippet: Effect of mutations in Rab27a on binding to Mlph and Munc13-4. Immunoblots showing coimmunoprecipitations are shown. A, Munc13-4 with Rab27a ( lanes 1 and 2 ), Rab27a-S163R ( lanes 3 and 4 ), and Rab27a-R141lfs ( lanes 5 and 6 ). Images are representative of 3 independent experiments. B, Rab27a ( lanes 1 and 2 ), Rab27a-S163R ( lanes 3 and 4 ), and Rab27a-R141lfs ( lanes 5 and 6 ) with Mlph. Membranes were probed with specific antibodies against Rab27a (top) or Mlph (bottom) . C and D, As above but with Rab27A A76V and Y159C. Proteins were immunoprecipitated with anti-Munc13-4 or Mlph and probed for Rab27a, Munc13-4, and Mlph.

Article Snippet: Lysates were precleared with 100 μL of Protein G Bead slurry (GE Healthcare, Fairfield, Conn) with rotating at 4°C for 30 minutes and then split into 3 samples: no antibody, rabbit anti-Rab27a (produced in rabbits immunized with human Rab27a-GST and screened against lysates from healthy donor and Rab27A-deficient human and mouse cell lines), and either goat anti–Munc13-4 (Everest Biotechnology, Upper Heyford, United Kingdom) or rabbit anti-Mlph (Abcam, Cambridge, United Kingdom).

Techniques: Binding Assay, Western Blot, Immunoprecipitation